Wendell Yarbrough, MD, is the new chief of otolaryngology [ENT]
He has a strong research background with a focus on tumor growth
Wendell G. Yarbrough, MD, MMHC, joined the practice on August 1 and will serve as the new section chief of otolaryngology at the Yale School of Medicine and Yale-New Haven Hospital. He will also direct the head and neck cancer program at Smilow Cancer Hospital and co-direct the molecular virology research program for Yale Cancer Center.
Dr. Yarbrough was previously a professor of otolaryngology and of cancer biology at Vanderbilt University. He was also the Ingram Professor of Cancer Research, and co-leader of the thoracic and head and neck program at the Vanderbilt Ingram Cancer Center. He served as director of the Barry Baker Laboratory of Head and Neck Oncology at Vanderbilt University.
His research concentrates on the identification of tumor suppressors in head and neck cancers and the understanding of tumor growth. He also focuses on the association between viruses and the development of cancer, particularly the link between the human papillomavirus and head and neck cancers.
Dr. Yarbrough completed his medical degree at the University of North Carolina School of Medicine. He completed his residency in otolaryngology head and neck surgery, and a fellowship in surgical oncology at the University of North Carolina at Chapel Hill.
He is a member of the American Academy of Otolaryngology, American Association for the Advancement of Science and American Association for Cancer Research. He is also a fellow of the American College of Surgeons and a member of the American College of Surgeons Oncology Group. Dr. Yarbrough’s research is supported by grants from the National Institutes of Health and the National Cancer Institute.